Categories: Technology

Mandatory disclosure of holding and notice of trade in IDEX Biometrics 23 July 2025

 | Source: IDEX BIOMETRICS ASA

Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider.

Tranche 1 of the private placement amounted to 4,731,594 shares. As disclosed separately, Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, participated in the private placement and subscribed for 739,360 shares in Tranche 1.

In connection with the private placement, the manager of the private placement, IDEX Biometrics and Mr. Storbråten entered into a share lending agreement.

Mr. Storbråten has lent 4,731,594 shares, ISIN NO0013536078, in connection with the settlement of Tranche 1. The shares have been lent, not sold, and will be returned in due course. 

After the subscription by Pinchcliffe and the temporary lending of shares, Mr. Storbråten and close relations hold 6,503,476 or 12,48% shares of the total outstanding shares and votes in IDEX Biometrics after completion of Tranche 1.

Contact person
Anders Storbråten, CEO and CFO
Tel: +47 4163 8582
E-mail: ir@idexbiometrics.com

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com

About this notice
This notice was issued by Erling Svela, Vice president of finance, on 23 July 2025 at 11:50 CET on behalf of IDEX Biometrics ASA. The information about the lending shall be disclosed according to article 19 no. 3 of the EU Market Abuse Regulation (EU 596/2014). The information about shareholding shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA). The information is published in accordance with section 5‑12 of the Norwegian Securities Trading Act.

GlobeNews Wire

Recent Posts

Armen Pogossian Represents Armenia at Forbes Under 30 Summit China, Empowering the Next Generation of Global Entrepreneurs

YEREVAN, Armenia, June 1, 2026 /PRNewswire/ -- Armen Pogossian, Owner of Pogossian Luxury Brand House,…

3 hours ago

Firstsource and AppliedAI Report Real-World Results from Strategic Partnership

Six months after its strategic investment, Firstsource announces proven outcomes from live deployments in healthcare…

3 hours ago

ANUA NAMES KENDALL JENNER AS FIRST-EVER GLOBAL BRAND AMBASSADOR

The Korean skincare brand debuts a global campaign, built around the PDRN Collagen Glow Facial Serum…

3 hours ago

Relativity Launches Relativity FOIA to Streamline Public Disclosure Operations for Government Agencies

News Summary:Relativity FOIA, a legal data intelligence solution for public disclosure operations, is now generally…

3 hours ago

Fee Brothers Launches Water-Soluble Fat Wash, Unlocking Savory Cocktails at Scale

Debuting in the U.S. June 1, with international availability this fall ROCHESTER, N.Y., June 1,…

3 hours ago

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle…

7 hours ago